Haemonetics Corp
(NYSE:HAE)

GET A REPORT ON HAE SENT RIGHT TO YOUR INBOX

$80.44
-0.15[-0.19%]
Last update: 1:11PM (Delayed 15-Minutes)
Get Real Time Here
$80.59
0.1500[0.19%]
After-Hours
Open80.590Close-
Vol / Avg.50.199K / 276.995KMkt Cap4.082B
Day Range80.040 - 81.06052 Wk Range72.260 - 95.260

Haemonetics Stock (NYSE:HAE), Guidance and Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Date Announced
ticker
Company Name
Period
Period Year
Min EPS
Max EPS
Estimate
Min Rev
Max Rev
Revenue Estimate
Get Alert
11/02/2023HAE
Haemonetics
FY2024$3.75$3.95$3.81$1.25B$1.27B$1.26BGet Alert
08/08/2023HAE
Haemonetics
FY2024$3.60$3.90$3.59$1.24B$1.27B$1.24BGet Alert
05/11/2023HAE
Haemonetics
FY2024$3.45$3.75$3.40$1.22B$1.25B$1.22BGet Alert
02/07/2023HAE
Haemonetics
FY2023$2.90$3.00$2.92$1.14B$1.16B$1.14BGet Alert
11/07/2022HAE
Haemonetics
FY2023$2.70$3.00$2.79$1.11B$1.14B$1.09BGet Alert
08/10/2022HAE
Haemonetics
FY2023$2.60$2.90$2.73$1.07B$1.10B$1.06BGet Alert
05/10/2022HAE
Haemonetics
FY2023$2.50$2.90$2.75$1.04B$1.08B$1.03BGet Alert
02/08/2022HAE
Haemonetics
FY2022$2.45$2.55$2.53$974.92M$992.33M$996.92MGet Alert
11/09/2021HAE
Haemonetics
FY2022$2.40$2.65$2.76$983.62M$1.02B$1.01BGet Alert
08/11/2021HAE
Haemonetics
FY2022$2.60$3.00$2.78$983.62M$1.03B$1.00BGet Alert
05/13/2021HAE
Haemonetics
FY2022$2.60$3.00$3.48$983.62M$1.03B$1.02BGet Alert
02/04/2020HAE
Haemonetics
FY2020$3.30$3.40$3.18$996.61M$1.02B$1.00BGet Alert
11/01/2019HAE
Haemonetics
FY2020$3.10$3.20$3.06$996.61M$1.02B$1.01BGet Alert
08/06/2019HAE
Haemonetics
FY2020$2.95$3.15$2.94$996.61M$1.02B$1.01BGet Alert
05/07/2019HAE
Haemonetics
FY2020$2.80$3.00$2.89$1.02B$1.03B$1.04BGet Alert
Q

What is the most recent guidance for Haemonetics (HAE)?

A

The last reported Earnings numbers were from November 2, 2023 for the full year 2024 and was for an earnings per share guidance in the range of $3.75 and $3.95 versus the estimated EPS of $3.81.

Browse guidance and forecast on all stocks.